Biogen Inc. buy Oppenheimer Holdings Inc.
Start price
31.10.24
/
50%
€160.90
Target price
31.10.25
€234.50
Performance (%)
-16.25%
End price
01.11.25
€134.75
Summary
This prediction ended on 01.11.25 with a price of €134.75. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.25%. Oppenheimer_Holdings has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -2.733% | -2.733% | 25.094% |
| iShares Core DAX® | 1.927% | -2.112% | 11.138% |
| iShares Nasdaq 100 | -0.184% | -5.899% | -0.151% |
| iShares Nikkei 225® | 7.076% | 6.457% | 28.830% |
| iShares S&P 500 | -0.201% | -3.667% | -0.104% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $270.00 to $255.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten